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This study investigated the effects of administration of monosodium L-
glutamate (MSG) on serum gonadotrophin-releasing hormone (GnRH), luteinis-
ing hormone (LH), testosterone and total cholesterol (TC), cauda epididymal 
sperm reserves (CESR) and testicular histomorphology of adult male albino rats. 
Eighty-four rats, randomly assigned to 7 groups of 12 rats each, were used for the 
study. Varying low doses (0.25, 0.50 or 1.00 g/kg body weight) of MSG were 
administered orally or subcutaneously at 48-h intervals for six weeks. Serum 
GnRH, LH, testosterone and TC, and CESR were evaluated on days 14, 28 and 42 
of MSG administration. Testicular histomorphology was evaluated on day 42. The 
results showed that the mean serum GnRH, LH and testosterone levels, and the 
CESR of all the treated groups were significantly (P < 0.05) lower than those of 
the untreated control on days 14, 28 and 42 of MSG administration. The mean se-
rum TC levels of all the treated groups were also significantly (P < 0.05) lower 
than those of the control group on days 14 and 28. No lesions were observed on 
sections of the testes. It was concluded that MSG administration for 14, 28 and 42 
days led to significantly lower serum levels of GnRH, LH, testosterone and TC, 
and significantly lower CESR.  
Key words: Monosodium L-glutamate, albino rats, reproductive hormones, 
cholesterol, epididymal sperm reserves, testicular histomorphology  
Monosodium glutamate (MSG) is the sodium salt of glutamate, which is 
used worldwide as a flavour-enhancing food additive (FSANZ – Food Standards 
Australia New Zealand, 2003). As of 2009, the total world production of MSG 
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was estimated to be 2 million tonnes per year (Sahelian, 2014). The consumption 
of MSG had been reported to be associated with numerous adverse effects 
(Raiten et al., 1995; FSANZ, 2003). Apart from the well-known Chinese restau-
rant syndrome consisting of diarrhoea, vomiting, migraine, weakness, stomach 
ache and tightness of chest, MSG consumption and/or experimental administra-
tion had been associated with stunted skeletal development, obesity, hepatotoxic-
ity, brain damage, deoxyribonucleic acid (DNA) damage, and neuroendocrine, 
reproductive, haematological and metabolic disorders among other things 
(JECFA – The Joint FAO/WHO Expert Committee on Food Additives, 1988; 
FASEB – Federation of American Societies for Experimental Biology, 1995; 
Gong et al., 1995; Bhattacharya et al., 2011; Igwebuike et al., 2011; Ismail, 
2012; Meraiyebu et al., 2012). 
There had been specific reports of adverse effects of MSG consumption or 
administration on the male reproductive system and hormones, mostly when very 
high doses of MSG are acutely administered parenterally (Ismail, 2012; Mohamed, 
2012; Nosseir et al., 2012). In order to simulate possible adverse effects that may 
be associated with normal consumption of MSG, the present study utilised lower 
doses and both oral and parenteral routes of administration – the oral represent-
ing the major route of consumption by humans. The albino rat was chosen as the 
model for this study because of its strengths and versatility as an animal model, 
its physiological similarity to humans and its appropriateness for repro-toxicity 
studies (Gallagher, 2003). The objectives of this study were therefore to evaluate 
the effects of oral and subcutaneous administration of varying low doses of MSG 
on serum gonadotrophin-releasing hormone (GnRH), luteinising hormone (LH), 
testosterone and total cholesterol (TC), cauda epididymal sperm reserves (CESR) 
and testicular histomorphology of adult male albino rats. 
 
 
Materials and methods 
Experimental animals 
Eighty-four adult male albino rats procured from and housed in the Labo-
ratory Animal House Unit of the Faculty of Veterinary Medicine, University of 
Nigeria, Nsukka were used for this study. Their body weight was 144.7–208.2 g 
and their age 12–15 weeks at the commencement of the study. Throughout the 
duration of the study, the rats were kept in standard clean rat cages and were fed 
ad libitum with pelleted feed (Grand Cereals and Oil Mills Limited, Jos-Nigeria) 
containing 16% crude protein. They were also provided freely with clean drink-
ing water throughout the study. 
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Monosodium L-glutamate 
The test compound used was Vedan® (99% MSG) brand of MSG 
(C5H8NNaO4.H2O), manufactured by Vedan Enterprise Corporation, Taiwan. It 
was dissolved in distilled water before use (Nayanatara et al., 2008). A stock so-
lution was prepared by dissolving a 454-g sachet of MSG crystals in distilled wa-
ter and made up to a volume of 1620 ml. Therefore, for groups BO and BS that 
received 0.25 g of MSG/kg body weight (bw), 0.9 ml/kg bw was given; for 
groups CO and CS that received 0.5 g of MSG/kg bw, 1.8 ml/kg bw was given; 
and for groups DO and DS that received 1.0 g of MSG/kg bw, 3.6 ml/kg bw was 
given. The dose schedule was so adjusted that the amount of MSG administered 
per animal corresponded to their body weight. 
Experimental design 
The 84 male albino rats were randomly assigned into seven groups (A, BO, 
BS, CO, CS, DO and DS) of 12 each. Group A served as the untreated control and 
therefore did not receive MSG. Groups BO and BS received 0.25 g of MSG/kg bw 
orally and subcutaneously (O/SC), respectively. Groups CO and CS received 0.5 g 
of MSG/kg bw O/SC, respectively. Groups DO and DS received 1 g of MSG/kg bw 
O/SC, respectively. The MSG administration (MSGA) was 48 hourly for a pe-
riod of six weeks. The serum levels of gonadotrophin releasing hormone (GnRH), 
luteinising hormone (LH), testosterone and total cholesterol; and testicular al-
lometric weights (testicular weights to body weights ratios) and epididymal 
sperm reserves were evaluated on days 14, 28 and 42 of MSGA. Body weights 
were determined on days 0, 14, 28 and 42 of MSGA. Testicular histomorphology 
was evaluated on day 42 of MSGA. 
Assay of serum levels of GnRH, LH and testosterone 
Enzyme-linked immunosorbent assay (ELISA) was used for the assay of 
GnRH, LH and testosterone (Ekins, 1998) on days 14, 28 and 42 of MSGA. The 
LH and testosterone test kits were of Accu-Bind brand manufactured by Mono-
bind Inc. (Lake Forest, CA 92630, USA), while the GnRH test kit was of 
NovaTeinBio brand manufactured by NovaTeinBio, Inc. (701 Concord Avenue, 
Cambridge, MA 02138, USA). The kits’ reagents were stored at the refrigeration 
temperature of 2–8 °C before use. 
Evaluation of serum total cholesterol 
Serum total cholesterol was determined on days 14, 28 and 42 of MSGA 
following the standard enzymatic colorimetric method (Allain et al., 1974), using 
Quimica Clinica Applicada (QCA) Cholesterol test kit (QCA, S. A., Spain). 
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Evaluation of epididymal sperm reserves  
The epididymal sperm reserves of male rats treated with MSG together 
with the controls were evaluated on days 14, 28 and 42 of MSGA. The sperm re-
serve of the cauda epididymides was assessed by employing the standard haemo-
cytometric method (Amman and Almquist, 1961). 
Determination of body weights and testicular allometric weights 
The body weights of male rats exposed to MSG together with the controls 
were determined on days 0, 14, 28 and 42 of MSGA, while the testicular allomet-
ric weights were determined on days 14, 28 and 42 of MSGA. A weighing bal-
ance of Ohaus brand (manufactured by Ohaus, USA) was used for weighing 
whole animals (determination of body weights). After this, the animals were hu-
manely sacrificed and the testes dissected out. A more sensitive Mettler weighing 
balance (manufactured by Mettler Toledo, Switzerland) was used for weighing 
the testes. The testicular weights were then divided by the respective body 
weights to get the testicular allometric weights. 
Histomorphological evaluation of the testis 
The testes were dissected from the male albino rats on day 42 of MSGA. 
They were fixed by immersion in Bouin’s solution for 48 h. Later, they were de-
hydrated in graded concentrations of ethanol, cleared in xylene, and embedded in 
paraffin wax. Five-micrometre thick sections were cut, mounted on glass slides, 
and stained with haematoxylin and eosin for light microscopy. Photomicrographs 
were captured using a Moticam Images Plus 2.0 digital camera (Motic China 
Group Ltd. 1999–2004). 
Data analysis 
Data generated were subjected to one-way analysis of variance (ANOVA). 
Variant means were separated using the least significant difference (LSD) method. 
Significance was accepted at a probability level less than 0.05 (P < 0.05). Histo-
logical pictures were analysed using a descriptive method. The results were then 
presented as tables and figures. 
Ethics 
The housing, handling and welfare of the albino rats used for the study 
were duly observed in accordance with the Ethics and Regulations Guiding the 
Use of Research Animals as approved by the University of Nigeria, Nsukka. 
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Results 
The mean serum levels of GnRH and LH of all the treatment groups were 
significantly (P < 0.05) lower than those of the control group on days 14, 28 and 
42 of MSGA (Tables 1 and 2). However, there were no significant (P > 0.05) 
variations in the mean serum GnRH and LH levels within the treatment groups 
on days 14, 28 and 42. The mean serum levels of testosterone of all the treatment 
groups were significantly (P < 0.05) lower than those of the control group on 
days 14, 28 and 42 of MSGA, with the exception of that of Group BS which did 
not significantly (P > 0.05) differ from that of the control group and other treat-
ment groups on day 28 (Table 3). Within the treatment groups, however, there 
were no significant (P > 0.05) variations in the mean serum testosterone levels on 
days 14, 28 and 42 of MSGA (Table 3). 
On day 14 of MSGA, the serum total cholesterol levels of rats in the 
treatment groups (except Group CO) were significantly (P < 0.05) lower than that 
of the untreated control, but on day 28 of MSGA the serum total cholesterol lev-
els of all the treatment groups (with no exception) were significantly (P < 0.05) 
lower than that of the untreated control (Table 4). However, on day 42 of MSGA, 
only the mean serum cholesterol levels of the groups treated through the subcu-
taneous route (BS, CS and DS) were found to be significantly (P < 0.05) lower 
than that of the control (Table 4). 
The mean cauda epididymal sperm reserves (CESR) of all the treated 
groups were significantly (P < 0.05) lower than those of the untreated control 
group on days 14, 28 and 42 of MSGA (Table 5). Within the treated groups, the 
groups given 1.0 g/kg bw of MSG subcutaneously (Groups DS) and the group 
treated orally with 1.0 g/kg bw of MSG (Group DO) had the lowest mean CESR 
on days 14 and 28 of MSGA, respectively (Table 5). 
There were no significant (P > 0.05) variations between the mean body 
weights of any of the rat groups on days 0, 14, 28 and 42 of MSGA (Table 6). 
There were no significant (P > 0.05) variations between the mean testicular al-
lometric weights of any of the rat groups on days 14, 28 and 42 of MSGA (Table 7). 
Sections of the testes of the albino rats that received varying doses of 
MSG orally or subcutaneously for six weeks showed normal seminiferous tu-
bules and interstices (Figs 1, 2 and 3). The morphology of the testes of all the 
male albino rat groups that were given MSG did not show any obvious lesions 
and was not different from that of the untreated control (Figs 1, 2 and 3). 
 
 
Discussion 
The significantly lower serum GnRH recorded in this study on days 14, 28 
and 42 of MSGA is thought to be due to neurological lesions (focal necrosis) of the 
arcuate nucleus of the hypothalamus reported to be associated with MSG treatment 
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Table 1 
Serum gonadotrophin-releasing hormone (GnRH) levels of male albino rats given varied doses of monosodium L-glutamate (MSG) per os or via 
the subcutaneous (SC) route for 42 days 
Means ± standard error (pg/ml) 
Groups, with treatments and route where applicable
Day 14 Day 28 Day 42 
Group A (untreated control) 23.33 ± 2.98a 16.74 ± 3.04a 17.61 ± 2.37a 
Group BO (0.25 g/kg bw MSG, per os) 9.41 ± 3.33b 5.08 ± 0.76b 4.07 ± 0.87b 
Group BS (0.25 g/kg bw MSG, SC) 8.57 ± 2.83b 4.69 ± 0.98b 3.28 ± 0.79b 
Group CO (0.5 g/kg bw MSG, per os) 8.71 ± 1.86b 5.14 ± 1.01b 4.22 ± 2.08b 
Group CS (0.5 g/kg bw MSG, SC) 7.18 ± 4.88b 2.97 ± 0.94b 4.14 ± 1.17b 
Group DO (1.0 g/kg bw MSG, per os) 5.95 ± 3.76b 2.72 ± 0.41b 2.63 ± 0.73b 
Group DS (1.0 g/kg bw MSG, SC) 6.58 ± 4.55b 2.65 ± 4.55b 2.54 ± 0.38b 
abDifferent superscripts within a column indicate a significant difference between the means (P < 0.05) 
Table 2 
Serum luteinising hormone (LH) levels of male albino rats given varied doses of monosodium L-glutamate (MSG) per os or via the subcutaneous 
(SC) route for 42 days 
Means ± standard error (× 10–2) (mIU/ml) 
Groups, with treatments and route where applicable
Day 14 Day 28 Day 42 
Group A (untreated control) 51.90 ± 13.60a 71.70 ± 7.60a 72.50 ± 4.80a 
Group BO (0.25 g/kg bw MSG, per os) 8.40 ± 1.80b 2.00 ± 0.20b 10.30 ± 3.80b 
Group BS (0.25 g/kg bw MSG, SC) 6.40 ± 0.20b 1.50 ± 0.20b 10.30 ± 3.00b 
Group CO (0.5 g/kg bw MSG, per os) 5.80 ± 1.60b 1.80 ± 0.30b 9.00 ± 1.90b 
Group CS (0.5 g/kg bw MSG, SC) 9.10 ± 4.70b 1.70 ± 0.20b 5.40 ± 1.80b 
Group DO (1.0 g/kg bw MSG, per os) 2.20 ± 0.10b 2.00 ± 0.30b 5.60 ± 1.30b 
Group DS (1.0 g/kg bw MSG, SC) 2.70 ± 1.10b 1.50 ± 0.20b 7.80 ± 2.00b 
abDifferent superscripts within a column indicate a significant difference between the means (P < 0.05) 
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Table 3 
Serum testosterone levels of male albino rats given varied doses of monosodium L-glutamate (MSG) per os or via the subcutaneous (SC) route for 
42 days 
Means ± standard error (ng/ml) 
Groups, with treatments and route where applicable
Day 14 Day 28 Day 42 
Group A (untreated control) 7.50 ± 1.14a 4.93 ± 1.18a 6.01 ± 0.29a 
Group BO (0.25 g/kg bw MSG, per os) 2.41 ± 0.93b 1.62 ± 0.50b 2.97 ± 0.53b 
Group BS (0.25 g/kg bw MSG, SC) 2.20 ± 0.65b 2.62 ± 0.10ab 2.97 ± 0.33b 
Group CO (0.5 g/kg bw MSG, per os) 1.36 ± 0.37b 1.15 ± 0.51b 2.45 ± 0.44b 
Group CS (0.5 g/kg bw MSG, SC) 1.23 ± 0.58b 1.56 ± 0.61b 2.54 ± 0.36b 
Group DO (1.0 g/kg bw MSG, per os) 1.69 ± 0.79b 2.01 ± 1.28b 2.48 ± 0.38b 
Group DS (1.0 g/kg bw MSG, SC) 1.21 ± 0.40b 1.05 ± 0.45b 2.21 ± 0.61b 
abDifferent superscripts within a column indicate a significant difference between the means (P < 0.05) 
Table 4 
Serum total cholesterol levels of male albino rats given varied doses of monosodium L-glutamate (MSG) per os or via the subcutaneous (SC) route 
for 42 days 
Means ± standard error (mg/dl) 
Groups, with treatments and route where applicable
Day 14 Day 28 Day 42 
Group A (untreated control) 117.18 ± 1.24a 103.00 ± 4.44a 111.04 ± 3.70a 
Group BO (0.25 g/kg bw MSG, per os) 97.14 ± 6.10bc 71.25 ± 4.07bc 100.43 ± 2.26ab 
Group BS (0.25 g/kg bw MSG, SC) 91.65 ± 3.70bcd 62.00 ± 0.82cd 76.61 ± 12.70c 
Group CO (0.5 g/kg bw MSG, per os) 102.38 ± 8.39ab 77.00 ± 2.65b 99.02 ± 1.46ab 
Group CS (0.5 g/kg bw MSG, SC) 81.17 ± 7.57cd 57.25 ± 8.62d 85.85 ± 5.22bc 
Group DO (1.0 g/kg bw MSG, per os) 99.31 ± 6.18b 60.50 ± 0.96cd 101.40 ± 2.34ab 
Group DS (1.0 g/kg bw MSG, SC) 79.08 ± 1.24d 55.50 ± 4.35d 93.60 ± 6.90abc 
abcdDifferent superscripts within a column indicate a significant difference between the means (P < 0.05) 
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Table 5 
Cauda epididymal sperm reserves of male albino rats given varied doses of monosodium L-glutamate (MSG) per os or via the subcutaneous (SC) 
route for 42 days 
Means ± standard error (× 106) 
Groups, with treatments and route where applicable
Day 14 Day 28 Day 42 
Group A (untreated control) 110.00 ± 13.00a 75.00 ± 4.67a 87.00 ± 15.00a 
Group BO (0.25 g/kg bw MSG, per os) 40.00 ± 5.24bc 25.00 ± 5.37bc 31.00 ± 8.49b 
Group BS (0.25 g/kg bw MSG, SC) 42.00 ± 12.00bc 16.00 ± 7.71c 39.00 ± 2.64b 
Group CO (0.5 g/kg bw MSG, per os) 62.00 ± 11.00b 36.00 ± 7.92b 34.00 ± 4.77b 
Group CS (0.5 g/kg bw MSG, SC) 51.00 ± 8.21bc 36.00 ± 7.34b 46.00 ± 7.10b 
Group DO (1.0 g/kg bw MSG, per os) 49.00 ± 5.91bc 14.00 ± 3.18c 43.00 ± 5.66b 
Group DS (1.0 g/kg bw MSG, SC) 30.00 ± 9.63c 20.00 ± 2.84bc 35.00 ± 10.00b 
abcDifferent superscripts within a column indicate a significant difference between the means (P < 0.05) 
Table 6 
Body weights of male albino rats given varied doses of monosodium L-glutamate (MSG) per os or via the subcutaneous (SC) route for 42 days 
Means ± standard error (g) 
Groups, with treatments and route where  
applicable Day 0 
(n = 12) 
Day 14 
(n = 12) 
Day 28 
(n = 8) 
Day 42 
(n = 4) 
Group A (untreated control) 177.60 ± 4.74 210.23 ± 5.24 235.84 ± 8.55 239.00 ± 8.56 
Group BO (0.25 g/kg bw MSG, per os) 177.93 ± 5.28 206.57 ± 5.81 229.36 ± 7.38 240.88 ± 3.21 
Group BS (0.25 g/kg bw MSG, SC) 176.66 ± 5.69 198.60 ± 6.23 224.03 ± 7.66 228.65 ± 9.27 
Group CO (0.5 g/kg bw MSG, per os) 176.83 ± 4.22 200.78 ± 4.89 215.88 ± 4.12 235.50 ± 0.81 
Group CS (0.5 g/kg bw MSG, SC) 178.88 ± 4.29 199.01 ± 4.64 226.55 ± 9.10 230.98 ± 3.43 
Group DO (1.0 g/kg bw MSG, per os) 180.12 ± 4.07 201.00 ± 4.22 217.24 ± 6.33 249.58 ± 8.90 
Group DS (1.0 g/kg bw MSG, SC) 179.60 ± 2.36 200.83 ± 2.86 232.63 ± 2.92 241.63 ± 9.64 
There was no significant difference between the means of different groups within a column (P > 0.05) 
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Table 7 
Testicular allometric weights of male albino rats given varied doses of monosodium L-glutamate (MSG) per os or via the subcutaneous (SC) route 
for 42 days 
Means ± standard error (× 10–2) 
Groups, with treatments and route where applicable
Day 14 Day 28 Day 42 
Group A (untreated control) 1.21 ± 0.07 1.15 ± 0.06 1.31 ± 0.10 
Group BO (0.25 g/kg bw MSG, per os) 1.16 ± 0.08 1.20 ± 0.06  1.12 ± 0.07 
Group BS (0.25 g/kg bw MSG, SC) 1.08 ± 0.08 1.09 ± 0.07 1.16 ± 0.09 
Group CO (0.5 g/kg bw MSG, per os) 1.21 ± 0.06  1.14 ± 0.05  1.15 ± 0.06 
Group CS (0.5 g/kg bw MSG, SC) 1.13 ± 0.04 1.22 ± 0.06 1.24 ± 0.09 
Group DO (1.0 g/kg bw MSG, per os) 1.17 ± 0.06 1.22 ± 0.10 1.09 ± 0.07 
Group DS (1.0 g/kg bw MSG, SC) 1.16 ± 0.07 1.19 ± 0.07 1.18 ± 0.06 
There was no significant difference between the means of different groups within a column (P > 0.05) 
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Fig. 1. Histological appearance of the testis of an albino rat given 0.5 g/kg body weight of MSG 
subcutaneously for 6 weeks, showing no obvious lesions. Haematoxylin and eosin (HE), × 100 
 
 
Fig. 2. Histological appearance of the testis of an albino rat given 1.0 g/kg body weight of MSG 
orally for 6 weeks, showing no obvious lesions. HE, × 400 
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Fig. 3. Histological appearance of the testis of an albino rat given 1.0 g/kg body weight of MSG 
subcutaneously for 6 weeks, showing no obvious lesions. HE, × 400 
 
in mice, rats and hamsters (Palkovits et al., 1974; Tafelski and Lamperti, 1977), 
as the arcuate nucleus of the hypothalamus secretes GnRH. The significantly 
lower serum LH recorded for the treated rats in this study is attributable to the 
significantly lower serum GnRH, as it is known that GnRH regulates the ability 
of the anterior pituitary gland to produce LH (Norris, 1997). The significantly 
lower serum LH reported in this study is in agreement with the findings of Gong 
et al. (1995). 
As cholesterol is known to be a precursor of steroid hormones (Stocco, 
1998; Hu et al., 2010), it is thought that the significantly lower serum testoster-
one levels recorded for the rats treated with MSG in this study may be partly due 
to the lowered serum cholesterol levels. The significantly lower serum testoster-
one may also be partly attributed to a disruption in the hypothalamic–pituitary–
testis regulatory axis (Nemeroff et al., 1981; Bodnár et al., 2001) mediated by the 
significantly lower serum levels of GnRH and LH recorded in the study. Lu-
teinising hormone specifically had been reported to be responsible for the stimu-
lation of testosterone production by the Leydig cells (McLachlan et al., 1996). 
The significantly lower serum cholesterol recorded for the rats treated with 
MSG in this study is thought to be related to the reported damage to the arcuate 
nucleus of the hypothalamus in animals given MSG as the arcuate nucleus of the 
hypothalamus had been reported to partly function in the regulation of fat me-
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tabolism (Dieguez et al., 2011). This lowered serum cholesterol is believed to be 
partly responsible for the significantly lower serum testosterone recorded for the 
MSG-treated rats, as testosterone is one of the steroid hormones synthesised 
from cholesterol (Stocco, 1998; Hu et al., 2010). The significantly lower serum 
cholesterol recorded for rats given MSG in this study is in agreement with the 
report of Bazzano et al. (1970) on humans and gerbils, but contrasts with the re-
ports of Ahluwalia and Malik (1989) and Inyang et al. (2012). 
It is believed that the significantly lower mean cauda epididymal sperm 
reserves recorded for the rat groups treated with MSG are directly related to their 
significantly lower serum testosterone levels as spermatogenesis is dependent on 
testosterone (Pakarainen et al., 2005; Wang et al., 2009; Walker, 2011). The find-
ings of a significantly lower mean CESR in rats given MSG in this study is in 
agreement with the reports of Igwebuike et al. (2011) and Fernandes et al. (2012). 
The experimental rats were equitably distributed into various groups, 
which accounted for no significant variations in their mean body weights across 
all the groups on day 0 of MSGA. Being growing adult rats, their body weights 
continued to increase during the course of the study. However, this increase in 
body weights occurred in all the groups at the same rate, thereby accounting for 
no significant variations in mean body weights in all the groups on days 14, 28 
and 42 of MSGA. This is in agreement with the report of Tordoff et al. (2012) 
who opined that previous studies that reported either significant increase or de-
crease in body weight associated with MSG involved administration of MSG to 
immature rodents, and consequently may not be relevant for understanding hu-
man obesity. 
The non-significant variations in the testicular allometric weights of all the 
rat groups show the absence of either hypogonadism or hypergonadism. This ob-
servation is probably due to the fact that the animals used in this study were adult 
rats. This finding is contrary to the reports of both testicular and ovarian hypo-
gonadism in male and female mice following a subcutaneous administration of 
MSG to neonatal mice at the dosage between 2.2 and 4.2 g per kg body weight 
(Pizzi et al., 1977). Also, Ebling et al. (1998), who made the same observation of 
hypogonadism of testes in hamsters, used a high dose of 4 g/kg body weight of 
MSG in their study in neonatal hamsters. Both contrary reports made use of 
higher doses of MSG and neonatal animals. These may have accounted for the 
differences between the observations made in this study and theirs. 
The non-observation of lesions in the sections of the testes of rats treated 
with MSG in this study is thought to be due to the relatively lower doses of MSG 
used for the study, which were meant to simulate intakes in humans. The find-
ings of no lesions in the testes of rats given MSG in this study are in agreement 
with the reports of Igwebuike et al. (2011) who used doses similar to the ones 
used in this study, but contrasts with those of Ismail (2012) and Nosseir et al. 
(2012) who administered higher doses at more regular intervals. 
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The choice of 0.25 g, 0.5 g and 1.0 g MSG per kg body weight for both 
oral and subcutaneous routes was made in a bid to as much as possible simulate 
the quantity of MSG taken by humans as a food additive. Data from the United 
Kingdom indicate an average intake of 590 mg MSG per day, with extreme users 
consuming 2,330 mg MSG per day (Rhodes et al., 1991). However, in a highly 
seasoned restaurant meal intakes as high as 5,000 mg MSG per day may be pos-
sible (Yang et al., 1997). The highest dose employed in this study is equal to the 
lowest dose used by Reynolds et al. (1971). They used 1, 2 and 4 g/kg, while Ol-
ney and Sharpe (1969) used a single dose of 2.7 g/kg that produced reproductive 
effects. The range of dosages producing an effect in the report of Allen et al. 
(1987) was 0.5 g to 2.5 g MSG. Other workers had used doses as high as 4–8 g or 
more MSG per kg body weight (Pizzi et al., 1977; Tafelski and Lamperti, 1977). 
Their choice of high doses of MSG may have been prompted by the fact that 
MSG has a very low acute toxicity, as the LD50 of MSG for rats and mice is 
about 15 g/kg and 18 g/kg body weight, respectively (JECFA, 1988). However, 
human consumption levels are not usually based on results of acute toxicity stud-
ies or LD50 calculations. 
In summary, administration of MSG to adult rats in three graded doses 
(0.25, 0.50 and 1.00 g/kg bw) and through two routes of administration (oral and 
subcutaneous routes) was associated with a significant lowering of the serum 
levels of GnRH, LH, testosterone and TC on days 14, 28 and 42 of administra-
tion. Rats treated with MSG also had a significantly lower CESR on days 14, 28 
and 42 of MSG administration. 
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